3.8 Letter

Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women

Journal

CANCER GENETICS AND CYTOGENETICS
Volume 199, Issue 1, Pages 69-72

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cancergencyto.2010.01.020

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal

Ekaterina S. Kuligina, Roman Meerovich, Kirill A. Zagorodnev, Maxim M. Kholmatov, Tatyana N. Sokolova, Tatiana A. Laidus, Aleksandr A. Romanko, Aleksandr S. Martianov, Maria O. Anisimova, Olga A. Zaitseva, Olga S. Yatsuk, Grigoriy A. Yanus, Evgeny N. Imyanito

Summary: This study found that the presence of ctDNA in plasma is characteristic for patients with progressing tumor disease. Consecutive plasma tests may occasionally provide discordant data, and repetition of analysis may be advised in certain cases to ensure the validity of negative ctDNA result.

CANCER GENETICS (2021)

Article Genetics & Heredity

Identification of recurrent pathogenic alleles using exome sequencing data: Proof-of-concept study of Russian subjects

Igor E. Orlov, Tatiana A. Laidus, Anastasia Tumakova, Grigoriy A. Yanus, Aglaya G. Iyevleva, Anna P. Sokolenko, Ilya Bizin, Evgeny N. Imyanitov, Evgeny N. Suspitsin

Summary: Whole exome sequencing is a powerful tool for identifying population-specific genetic diseases. This study found recurrent pathogenic alleles in a small number of individual Russian exomes, with some being non-Russian-specific and others characteristic for subjects of Russian origin.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2022)

Article Oncology

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer

Fedor Moiseyenko, Ekaterina S. Kuligina, Albina S. Zhabina, Sergey A. Belukhin, Tatiana A. Laidus, Aleksandr S. Martianov, Kirill A. Zagorodnev, Tatyana N. Sokolova, Svetlana A. Chuinyshena, Maxim M. Kholmatov, Elizaveta Artemieva, Ekaterina O. Stepanova, Tatiana N. Shuginova, Nikita M. Volkov, Grigoriy A. Yanus, Evgeny N. Imyanitov

Summary: The study found that changes in EGFR-mutated ctDNA concentration at 48 hours after the start of therapy can predict the duration of efficacy of TKIs.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Tumor irradiation may facilitate the detection of tumor-specific mutations in plasma

Ekaterina Kuligina, Fedor Moiseyenko, Sergey Belukhin, Ekaterina Stepanova, Maria Zakharova, Vera Chernobrivtseva, Ikram Aliev, Tatiana Sharabura, Vladimir Moiseyenko, Svetlana Aleksakhina, Tatiana Laidus, Aleksandr Martianov, Maksim Kholmatov, Aldon Whitehead, Grigoriy Yanus, Evgeny Imyanitov

Summary: The mutation-based analysis of circulating tumor DNA is a promising diagnostic tool for clinical oncology. Preoperative tumor irradiation may transiently increase plasma ctDNA concentration due to induction of apoptosis. Local tumor irradiation may facilitate the detection of tumor-specific DNA in the bloodstream, supporting further evaluation of irradiation-assisted liquid biopsy.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations

G. A. Yanus, E. L. Savonevich, A. P. Sokolenko, A. A. Romanko, V. Ni, E. Kh Bakaeva, O. A. Gorustovich, I. Bizin, E. N. Imyanitov

Summary: The study found that BRCA1/2 gene mutations in Belarusian population show a high level of founder allele effect. This is surprising as the population of Belarus did not experience geographic or cultural isolation throughout history.

FAMILIAL CANCER (2023)

Article Biochemistry & Molecular Biology

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1

Natalia V. Mitiushkina, Grigory A. Yanus, Ekatherina Sh. Kuligina, Tatiana A. Laidus, Alexandr A. Romanko, Maksim M. Kholmatov, Alexandr O. Ivantsov, Svetlana N. Aleksakhina, Evgeny N. Imyanitov

Summary: DNA from formalin-fixed paraffin-embedded (FFPE) tissues is prone to chemical degradation, affecting mutation detection accuracy. By replacing DNA polymerase with a single strand-specific nuclease P1, researchers improved the performance of duplex sequencing in FFPE-derived DNA, resulting in more accurate mutation detection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas

Aleksandr S. Martianov, Natalia V. Mitiushkina, Anastasia N. Ershova, Darya E. Martynenko, Mikhail G. Bubnov, Priscilla Amankwah, Grigory A. Yanus, Svetlana N. Aleksakhina, Vladislav I. Tiurin, Aigul R. Venina, Aleksandra A. Anuskina, Yuliy A. Gorgul, Anna D. Shestakova, Mikhail A. Maidin, Alexey M. Belyaev, Liliya S. Baboshkina, Aglaya G. Iyevleva, Evgeny N. Imyanitov

Summary: This study analyzed the factors influencing the distribution of actionable genetic alterations in colorectal carcinomas. The study found that there were differences in the distribution of certain genetic alterations based on patients' age and gender. BRAF mutation frequency also showed geographic variation. In addition, a small fraction of CRCs had simultaneous alterations in more than one driver gene.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus

Anna P. Sokolenko, Elvina Kh. Bakaeva, Aigul R. Venina, Ekaterina Sh. Kuligina, Alexandr A. Romanko, Svetlana N. Aleksakhina, Yana V. Belysheva, Evgeniya V. Belogubova, Ilya A. Stepanov, Olga A. Zaitseva, Olga S. Yatsuk, Alexandr V. Togo, Zaur M. Khamgokov, Azinat O. Kadyrova, Albert Sh. Pirmagomedov, Marina B. Bolieva, Alexandr A. Epkhiev, Aslan K. Tsutsaev, Madina D. Chakhieva, Khalimat M. Khabrieva, Idris M. Khabriev, Mirza A. Murachuev, Bella N. Buttaeva, Liliya S. Baboshkina, Fatima I. Bayramkulova, Islam R. Katchiev, Lina Kh. Alieva, Grigory A. Raskin, Sergey V. Orlov, Zarema K. Khachmamuk, Karine R. Levonyan, Dariya M. Gichko, Dmitriy V. Kirtbaya, Alexey M. Degtyariov, Luisa V. Sultanova, Hedi S. Musayeva, Alexey M. Belyaev, Evgeny N. Imyanitov

Summary: This study reveals the global-wide contribution of BRCA1/2 genes to high-grade serous ovarian cancer (HGSOC) and breast cancer (BC) morbidity in the North Caucasus region, although the spectrum of their pathogenic variants (PVs) shows ethnicity-specific variations. The data on founder BRCA1/2 alleles can be considered when adjusting the testing procedure to the ethnic origin of patients.

BREAST CANCER RESEARCH AND TREATMENT (2023)

Article Medicine, General & Internal

Molecular Analysis of Biliary Tract Cancers with the Custom 3′ RACE-Based NGS Panel

Natalia V. Mitiushkina, Vladislav I. Tiurin, Aleksandra A. Anuskina, Natalia A. Bordovskaya, Anna D. Shestakova, Aleksandr S. Martianov, Mikhail G. Bubnov, Anna S. Shishkina, Maria V. Semina, Aleksandr A. Romanko, Ekaterina S. Kuligina, Evgeny N. Imyanitov

Summary: The combination of 3' RACE technology with targeted RNA sequencing panel is an efficient tool for molecular diagnostics of biliary tract carcinomas.

DIAGNOSTICS (2023)

Letter Oncology

Northern origin of the BRCA2 c.5286 T > G founder allele

Grigory A. Yanus, Anna P. Sokolenko, Evgeny N. Imyanitov

BREAST CANCER RESEARCH AND TREATMENT (2023)

Article Oncology

Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine

Tatiana N. Sokolova, Valeriy V. Breder, Irina S. Shumskaya, Evgeny N. Suspitsin, Svetlana N. Aleksakhina, Grigoriy A. Yanus, Vladislav I. Tiurin, Alexandr O. Ivantsov, Barbara Vona, Grigoriy A. Raskin, Sergey V. Gamajunov, Evgeny N. Imyanitov

Summary: This case highlights the importance of proper interpretation of genetic testing results and the potential impact of family history on cancer treatment decisions. It also demonstrates the need for rigorous clinical expertise in medical laboratory facilities to avoid errors and misinterpretations.

HEREDITARY CANCER IN CLINICAL PRACTICE (2021)

Article Genetics & Heredity

Aberrant COL11A1 splicing causes prelingual autosomal dominant nonsyndromic hearing loss in the DFNA37 locus

Aboulfazl Rad, Thore Schade-Mann, Philipp Gamerdinger, Grigoriy A. Yanus, Bjoern Schulte, Marcus Mueller, Evgeny N. Imyanitov, Saskia Biskup, Hubert Loewenheim, Anke Tropitzsch, Barbara Vona

Summary: COL11A1-encoded alpha-chain collagen molecules are crucial for skeletal, ocular, and auditory function. Variants in COL11A1 have been associated with syndromes affecting these systems. This study provides evidence that splice-altering variants in COL11A1 cause DFNA37 hearing loss, emphasizing the importance of including COL11A1 in genetic testing for nonsyndromic deafness.

HUMAN MUTATION (2021)

No Data Available